TheMarker.com
Rothschild group, Pasteur Institute wrap up $60m for Israeli-oriented biotech fund
05/12/02 - 10:12 AM EDT
- Article Tools
- Email this Article
- Print this Article
- Rss Feed
- Related Articles
- Del.icio.us
- Digg
- StumbleUpon
The Compagnie Financière Edmond de Rothschild, of the Rothschild banking group, and the Pasteur Institute are wrapping up a $60 million financing round for biotechnology investments.
The fund, BioDiscovery 2, will target both European and Israeli biotechnology endeavors, Professor Max Herzberg told TheMarker today.
The first BioDiscovery fund had invested in three Israeli firms.
BioDiscovery Israel, run by Herzberg, is contending for the biotechnology incubator tender issued by the Israeli Ministry of Industry and Trade. The tender is for the management of two biotechnology incubators.
Herzberg also chairs the Eager Biogroup incubator in Ashdod, and is a partner in running the Biotop biotechnology incubator of the Pasteur Institute in Paris together with Dr Christian Policard.
Yahoo! is among the most searched stocks on TheStreet.com. Here's what Cramer had to say about the stock recently.
Catch up on his thinking on the hottest topics of the past week.
Investors will have to deal with a Fed meeting and another flood of earnings and economic data.
Ensco International and Echelon have the potential to move higher in coming days.
See who made what calls.
The addition of video is helping telecom companies compete against cable and satellite companies.
The June West Texas Intermediate contract reflects selling pressure ahead of Tuesday's expiration. But stocks in the sector are generally trading higher.
See who made what calls.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Sponsored by:
RSS
